The HMS Cancer Biology and Therapeutics (CBT) program is a 12-month blended-learning program designed to provide participants with deep knowledge of the cancer biology that shapes modern preventive and therapeutic approaches.
Participants in the CBT program will develop this expertise through an understanding of the molecular, cellular and host events that drive tumor formation, progression, and metastasis. How this knowledge is being used to develop our growing set of therapeutic and preventive approaches to fight cancer will be highlighted along with opportunities for participants to consider what new strategies are in development now.
The program will cover important topics in screening, detection and diagnosis, as well as studies in clinical cancer genetics, pathology, and drug development. Leading faculty from HMS, HMS-affiliated hospitals, and other schools at Harvard, as well as other leading international institutions and organizations will be involved, both as faculty and as mentors [read more about the CBT Program].